Chemed Corp Stock News

Chemed Corporation (Chemed) (NYSE: CHE), which operates VITAS Healthcare Corporation (VITAS), one of the nation’s largest providers of end-of-life care, and Roto-Rooter, the nation’s largest comme

EULAV Asset Management grew its holdings in Chemed Co. (NYSE:CHE) by 7.6% during the 1st quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The fund owned

Chemed sees updating 2020 earnings guidance in July CHE

Chemed reports Q1 adjusted EPS $3.68, consensus $3.65 CHE

Companies Reporting Before The Bell Caterpillar Inc. (NYSE: CAT) is projected to report quarterly earnings at $1.68 per share on revenue of $10.92 billion. United Parcel Service...

Chemed (NYSE:CHE) is scheduled to announce Q1 earnings results on Tuesday, April 28th, after market close.The consensus EPS Estimate is $3.65 (+25.0% Y/Y) and the consensus Revenue Estimate is $523.04

Is (CHE) Outperforming Other Medical Stocks This Year?

Is (CHE) Outperforming Other Medical Stocks This Year?

Baxter's (BAX) first-quarter performance is likely to reflect growth in its six global business units.

Stryker's (SYK) first-quarter earnings likely to reflect strong segmental performances by Medsurg and Neurotechnology & Spine.

Chemed (CHE) is seeing favorable earnings estimate revision activity and has a positive Zacks Earnings ESP heading into earnings season.

Chemed (CHE) is seeing favorable earnings estimate revision activity and has a positive Zacks Earnings ESP heading into earnings season.

There have been 133 notices and acknowledgements printed in our sister title, The Herald, over the past two weeks

Juniper's (JNPR) first-quarter 2020 performance is likely to have benefited from changes to its go-to-market structure to better align sales strategies with each of the core customer verticals.